EyePoint (EYPT) Accounts Payables (2011 - 2026)
EyePoint (EYPT) reported Accounts Payables of $18.8 million for Q1 2026, up 14.58% on a YoY basis from $16.4 million in Q1 2025, and up 79.34% sequentially from $10.5 million in Q4 2025.
EyePoint (EYPT) Accounts Payables (2011 - 2026) Analysis & Trends
EyePoint (EYPT) has 16 years of Accounts Payables data on file, last reported at $18.8 million in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables rose 14.58% year-over-year to $18.8 million; the trailing twelve-month figure through Mar 2026 stood at $18.8 million (up 14.58% YoY), and the FY2025 full-year result was $10.5 million, down 10.5% from the prior year.
- Accounts Payables grew to $18.8 million in Q1 2026, from $10.5 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $19.7 million in Q2 2025 to a low of $5.9 million in Q4 2022.
- A 5-year average of $10.5 million and a median of $9.6 million in 2023 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables slipped 25.08% in 2024 and soared 131.84% in 2025, its largest moves.
- Tracing EYPT's Accounts Payables over 5 years: stood at $5.9 million in 2022, then increased by 9.88% to $6.5 million in 2023, then jumped by 80.21% to $11.7 million in 2024, then declined by 10.5% to $10.5 million in 2025, then surged by 79.34% to $18.8 million in 2026.
- Business Quant data shows EYPT's Accounts Payables at $18.8 million in Q1 2026, $10.5 million in Q4 2025, and $10.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | 18.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.81 Mn |
| Dec 31, 2025 | 10.49 Mn |
| Sep 30, 2025 | 10.08 Mn |
| Jun 30, 2025 | 19.69 Mn |
| Mar 31, 2025 | 16.42 Mn |
| Dec 31, 2024 | 11.72 Mn |
| Sep 30, 2024 | 7.34 Mn |
| Jun 30, 2024 | 14.30 Mn |
| Mar 31, 2024 | 7.08 Mn |
| Dec 31, 2023 | 6.50 Mn |
| Sep 30, 2023 | 9.58 Mn |
| Jun 30, 2023 | 10.72 Mn |
| Mar 31, 2023 | 9.45 Mn |
| Dec 31, 2022 | 5.92 Mn |
| Sep 30, 2022 | 6.11 Mn |
| Jun 30, 2022 | 7.06 Mn |
| Mar 31, 2022 | 7.30 Mn |
| Dec 31, 2021 | 7.39 Mn |
| Sep 30, 2021 | 6.64 Mn |
| Jun 30, 2021 | 5.42 Mn |